Skip to main content
LLY
NYSE Life Sciences

礼来公司以高达23亿美元的价格收购Ajax Therapeutics，增强血液癌药物管线

feedReported by dpa-AFX
Sentiment info
Positive
Importance info
8
Price
$916.02
Mkt Cap
$865.473B
52W Low
$623.78
52W High
$1,133.95
Market data snapshot near publication time

summarizeSummary

礼来公司已同意以高达23亿美元的价格收购Ajax Therapeutics，一家专注于下一代JAK2抑制剂的临床阶段生物技术公司。本次收购包括预付款和与临床和监管成就相关的里程碑式付款。该战略举措旨在加强礼来公司在血液癌治疗领域的地位，并加速Ajax的主要候选药物AJ1-11095的开发。这是礼来公司的一项重大并购事件，代表了最近时间表中以前未捕获的新信息

在该公告发布时，LLY的交易价格为$916.02，交易所为NYSE，所属行业为Life Sciences，市值约为$8654.7亿。 52周交易区间为$623.78至$1,133.95。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：dpa-AFX。

show_chartPrice Chart

Share this article

Copied!

feed LLY - Latest Insights

LLY
May 01, 2026, 7:57 AM EDT
Source: Reuters
Importance Score:
8
Lilly's Foundayo Oral Obesity Drug Reaches Nearly 6,000 Prescriptions in Third Week Post-Launch
Sentiment: Neutral
View Wiseek Article
LLY
Apr 30, 2026, 11:25 AM EDT
Filing Type: 10-Q
Importance Score:
9
Eli Lilly Reports Exceptional Q1 Growth Driven by Mounjaro & Zepbound, Announces $1.1B Acquisition and $2.3B Share Repurchase
Sentiment: Positive
View Wiseek Article
LLY
Apr 30, 2026, 10:50 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Lilly USA President Foresees Strong GLP-1 Persistence in Medicare Population
Sentiment: Positive
View Wiseek Article
LLY
Apr 30, 2026, 10:17 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Medicaid Access Loss Dents Lilly's Q1 Prescription Growth by High Single Digits
Sentiment: Negative
View Wiseek Article
LLY
Apr 30, 2026, 10:02 AM EDT
Source: dpa-AFX
Importance Score:
8
Eli Lilly to Acquire Ajax Therapeutics for Up to $2.3 Billion, Boosting Blood Cancer Pipeline
Sentiment: Positive
View Wiseek Article
LLY
Apr 30, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
9
Eli Lilly Reports Soaring Q1 Revenue & EPS, Raises Full-Year Guidance, and Secures Key FDA Approval
Sentiment: Positive
View Wiseek Article
LLY
Apr 30, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Eli Lilly Projects $82B-$85B in Full-Year Revenue
Sentiment: Neutral
View Wiseek Article
LLY
Apr 29, 2026, 4:07 PM EDT
Source: Wiseek News
Importance Score:
8
Investigational Retatrutide Shows 23.7% Weight Loss; Eli Lilly's Q1 Earnings Report Imminent
Sentiment: Positive
View Wiseek Article
LLY
Apr 29, 2026, 1:44 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Weight-Loss Drug Demand Fuels Expected Triple-Digit Q1 Profit Growth for Eli Lilly
Sentiment: Positive
View Wiseek Article
LLY
Apr 29, 2026, 1:18 PM EDT
Filing Type: PX14A6G
Importance Score:
7
Shareholders Push for Independent Board Chair Citing New Antitrust Allegations and Legal Risks
Sentiment: Negative
View Wiseek Article